University of Pennsylvania

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1740-11-14

Employees: 5K

Market Cap: -

Website: http://www.upenn.edu

Clinical Trials

Circadian Brown Adipose Tissue Metabolism

Not Applicable

Completed

Conditions: Healthy

Interventions: Device: FDG PET/CT

First Posted Date: 2014-11-06

Last Posted Date: 2016-12-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 10

Registration Number: NCT02285270

Locations: 🇺🇸
University of Pennsylvania, Philadelphia, Pennsylvania, United States

Indocyanine Green for Solid Tumors

Phase 1

Completed

Conditions: Solid Tumor
Neoplasms

Interventions: Drug: Indocyanine Green (ICG)

First Posted Date: 2014-11-02

Last Posted Date: 2018-03-20

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 48

Registration Number: NCT02280954

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

CD19 Redirected Autologous T Cells for Hodgkin Lymphoma

Early Phase 1

Terminated

Conditions: Hodgkin Lymphoma With no Available Curative Treatment Options Who Have a Limited Prognosis

Interventions: Biological: RNA anti-CD19 CAR T cells

First Posted Date: 2014-10-29

Last Posted Date: 2023-06-22

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 4

Registration Number: NCT02277522

Locations: 🇺🇸
Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Serial [18F]Thymidine (FLT)PET/CT as a Biomarker of Response in Pemetrexed Therapy for Non-Small Cell Lung Cancer

Not Applicable

Terminated

Conditions: Non-small Cell Lung Cancer
Starting Pemetrexed Based Therapy
Unresectable Cancer

Interventions: Drug: Baseline 18F-thymidine (FLT) PET/CT
Drug: Post-therapy 18F-thymidine (FLT) PET/CT to assess for pemetrexed induced tumor FLT "flare"
Drug: Post-therapy 18F-thymidine (FLT) PET/CT to assess for pemetrexed induced changes in tumor proliferation

First Posted Date: 2014-10-24

Last Posted Date: 2021-05-12

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3

Registration Number: NCT02274038

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Individualized Comparative Effectiveness of Models Optimizing Patient Safety and Resident Education.

Not Applicable

Completed

Conditions: Education, Medical
Safety
Sleep

Interventions: Behavioral: Flexible Duty Hour Schedule

First Posted Date: 2014-10-24

Last Posted Date: 2020-09-04

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 3500

Registration Number: NCT02274818

Families Taking Control (FTC): Family-based Problem-solving Intervention for Children With Sickle Cell Disease

Not Applicable

Completed

Conditions: Sickle Cell Disease

Interventions: Behavioral: Problem-Solving Skills Training for Disease Management

First Posted Date: 2014-10-23

Last Posted Date: 2016-01-07

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 83

Registration Number: NCT02273310

Handoffs and Transitions in Critical Care

Not Applicable

Completed

Conditions: Intensive Care Units
Patient Safety
Healthcare Team
Patient Handoff
Communication

Interventions: Behavioral: Standardized handoff

First Posted Date: 2014-10-17

Last Posted Date: 2020-06-26

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 1000

Registration Number: NCT02267174

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States
🇺🇸
Penn Presbyterian Medical Center, Philadelphia, Pennsylvania, United States

The Causal Impact of Online Social Media on Physical Activity: A Randomized Controlled Trial

Not Applicable

Completed

Conditions: Physical Activity

Interventions: Behavioral: Social network-assisted fitness program
Behavioral: Media-assisted fitness program
Behavioral: Basic fitness program

First Posted Date: 2014-10-17

Last Posted Date: 2014-10-17

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 217

Registration Number: NCT02267369

Pharmacokinetics, Pharmacodynamics, and Impact of Inorganic Nitrate on Exercise in HFpEF

Phase 2

Completed

Conditions: Heart Failure
Diastolic Heart Failure

Interventions: Drug: KNO3
Drug: KCl

First Posted Date: 2014-10-03

Last Posted Date: 2017-10-03

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 12

Registration Number: NCT02256345

Locations: 🇺🇸
Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, United States

Exploratory Study of Circadian Relationships Between Social Behavior, Blood Pressure and Metabolomics

Completed

Conditions: Healthy

First Posted Date: 2014-09-26

Last Posted Date: 2020-01-18

Lead Sponsor: University of Pennsylvania

Target Recruit Count: 6

Registration Number: NCT02249793

Locations: 🇺🇸
Institute for Translational Medicine and Therapeutics (ITMAT), University of Pennsylvania, Philadelphia, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy